中信建投医改混合C(007553)利润分配表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
收入 |
-344,340,933.22 |
-274,469,918.05 |
-228,510,170.84 |
-315,390,211.05 |
利息合计 |
348,534.34 |
110,066.22 |
477,710.66 |
177,793.23 |
其中:存款利息收入 |
348,534.34 |
110,066.22 |
477,710.66 |
177,793.23 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益合计 |
-147,071,246.50 |
-102,250,918.01 |
-254,695,638.05 |
-33,858,257.11 |
其中:股票投资收益 |
-158,724,283.03 |
-109,785,901.29 |
-262,154,360.88 |
-36,740,187.86 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
2,783,776.82 |
2,466,821.11 |
-7,572,048.05 |
-7,694,257.86 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
8,869,259.71 |
5,068,162.17 |
15,030,770.88 |
10,576,188.61 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
-198,319,559.35 |
-172,604,297.56 |
24,874,148.94 |
-282,186,707.87 |
其他收入 |
701,338.29 |
275,231.30 |
833,607.61 |
476,960.70 |
费用 |
19,851,705.97 |
10,583,936.80 |
27,442,780.29 |
14,966,124.44 |
管理人报酬 |
14,010,227.34 |
7,470,324.29 |
19,239,777.20 |
10,447,471.46 |
基金托管费 |
2,802,045.42 |
1,494,064.87 |
3,847,955.49 |
2,089,494.31 |
销售服务费 |
2,835,227.05 |
1,510,487.58 |
3,913,475.47 |
2,098,008.79 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
222,351.75 |
222,351.75 |
其中:卖出回购金融资产支出 |
- |
- |
222,351.75 |
222,351.75 |
其他费用 |
204,200.00 |
109,053.90 |
219,200.00 |
108,778.95 |
利润总额 |
-364,192,639.19 |
-285,053,854.85 |
-255,952,951.13 |
-330,356,335.49 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年